Butyrate increases the efficiency of translation of γ-globin mRNA

被引:70
作者
Weinberg, RS
Ji, X
Sutton, M
Perrine, S
Galperin, Y
Li, Q
Liebhaber, SA
Stamatoyannopoulos, G
Atweh, GF
机构
[1] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY USA
[2] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] Boston Univ, Sch Med, Hemoglobinopathy Thalassemia Res Unit, Boston, MA 02118 USA
[5] Univ Washington, Div Med Genet, Seattle, WA 98195 USA
关键词
D O I
10.1182/blood-2004-02-0454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fetal hemoglobin (Hb F) levels increase in most patients with sickle cell disease following intermittent butyrate therapy. Although the full effects of butyrate on Hb F levels usually require multiple treatment cycles, in some patients a peak level is achieved after a few. days of butyrate therapy. Our investigation of the mechanism(s) responsible for this rapid induction of Hb F by butyrate showed that reticulocyte gamma-globin chain synthesis markedly increased within 24 hours of butyrate exposure, without concomitant,changes in reticulocyte gamma-globin mRNA levels. This suggests that butyrate might induce Hb F by increasing the efficiency of translation of gamma-globin mRNA. This hypothesis was confirmed by ribosome loading studies that demonstrated enrichment of the polysomal fraction of reticulocytes with gamma-globin mRNA following butyrate exposure. Thus, the induction of Hb F by butyrate may be mediated by translational effects in addition to its well-known effects on transcription of the, gamma-globin genes. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:1807 / 1809
页数:3
相关论文
共 29 条
[1]  
Atweh GF, 1999, BLOOD, V93, P1790
[2]  
BARD H, 1985, PEDIATRICS, V75, P1143
[3]   EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].
CHARACHE, S ;
TERRIN, ML ;
MOORE, RD ;
DOVER, GJ ;
BARTON, FB ;
ECKERT, SV ;
MCMAHON, RP ;
BONDS, DR ;
ORRINGER, E ;
JONES, S ;
STRAYHORN, D ;
ROSSE, W ;
PHILLIPS, G ;
PEACE, D ;
JOHNSONTELFAIR, A ;
MILNER, P ;
KUTLAR, A ;
TRACY, A ;
BALLAS, SK ;
ALLEN, GE ;
MOSHANG, J ;
SCOTT, B ;
STEINBERG, M ;
ANDERSON, A ;
SABAHI, V ;
PEGELOW, C ;
TEMPLE, D ;
CASE, E ;
HARRELL, R ;
CHILDERIE, S ;
EMBURY, S ;
SCHMIDT, B ;
DAVIES, D ;
KOSHY, M ;
TALISCHYZAHED, N ;
DORN, L ;
PENDARVIS, G ;
MCGEE, M ;
TELFER, M ;
DAVIS, A ;
CASTRO, O ;
FINKE, H ;
PERLIN, E ;
SITEMAN, J ;
GASCON, P ;
DIPAOLO, P ;
GARGIULO, S ;
ECKMAN, J ;
BAILEY, JH ;
PLATT, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322
[4]  
CHARACHE S, 1987, BLOOD, V69, P109
[5]  
CONSTANTOULAKIS P, 1988, BLOOD, V72, P1961
[6]  
CONSTANTOULAKIS P, 1989, BLOOD, V74, P1963
[7]  
DOVER GJ, 1994, BLOOD, V84, P339
[8]  
DOVER GJ, 1985, BLOOD, V66, P527
[9]   ACTIVATION OF A CHICKEN EMBRYONIC GLOBIN GENE IN ADULT ERYTHROID-CELLS BY 5-AZACYTIDINE AND SODIUM-BUTYRATE [J].
GINDER, GD ;
WHITTERS, MJ ;
POHLMAN, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (13) :3954-3958
[10]   Alterations in protein-DNA interactions in the γ-globin gene promoter in response to butyrate therapy [J].
Ikuta, T ;
Kan, YW ;
Swerdlow, PS ;
Faller, DV ;
Perrine, SP .
BLOOD, 1998, 92 (08) :2924-2933